Fig. 1: Association between polygenic risk score (PRS) for vitamin D levels and symptom severity in the AthensFEP study.

The variance explained (R²) for PANSS subscale scores by different PRS-vitD P_T thresholds is shown at baseline and after 4 weeks of antipsychotic treatment (^ap < 0.05, ^bp < 0.001).